Brain Monitoring Market Segmentation:
Product Segment Analysis
Among the product types, the transcranial doppler devices (TCD) segment in the brain monitoring market is poised to have the highest growth during the forecast period. The device is used for ultrasound and uses sound waves to monitor the blood flow in the brain. In October 2022, WHO published a report highlighting a 50% increase in stroke cases globally over the last 27 years, and that 1 in 4 people is estimated to suffer from a stroke in their lifetime. The increasing number of cases of stroke is the primary driver in the growth of the TCD segment. In 2022, Viasonix reported that there was a 75% increase in the sales of their TCD devices.
The electroencephalography (EEG) devices segment is expected to register rapid revenue growth by 2035 owing to rising demand for non-invasive diagnostic process, increasing neurological disorders, and rising availability of technological advancements in EEG products.
End use Segment Analysis
The hospitals segment holds a significant brain monitoring market share and is expected to continue to grow steadily during the forecast period. The growth of the hospital segment coincides with increased spending on neurological care. Countries such as the U.S, Switzerland, and Germany, spend a considerable amount on healthcare, allowing hospitals to have the necessary funds to set up quality infrastructure.
In 2023, WHO released the Intersectoral Global Action Plan (IGAP) on neurological disorders, poised to lead to greater investments in neurological care. Hospitals see the highest footfall of patients for various neurological conditions such as multiple sclerosis, epilepsy, mental illnesses, Alzheimer's, brain tumors, and traumatic brain injuries due to which the use of brain monitoring in hospitals is higher compared to other segments.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
Procedure |
|
|
Application |
|
|
End use |
|
